OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PDGFRα: a new therapeutic target in the treatment of hepatocellular carcinoma?
Abdul M. Oseini, Lewis R. Roberts
Expert Opinion on Therapeutic Targets (2009) Vol. 13, Iss. 4, pp. 443-454
Closed Access | Times Cited: 46
Abdul M. Oseini, Lewis R. Roberts
Expert Opinion on Therapeutic Targets (2009) Vol. 13, Iss. 4, pp. 443-454
Closed Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
Keratin 19: a key role player in the invasion of human hepatocellular carcinomas
Olivier Govaere, Mina Komuta, J. Berkers, et al.
Gut (2013) Vol. 63, Iss. 4, pp. 674-685
Open Access | Times Cited: 246
Olivier Govaere, Mina Komuta, J. Berkers, et al.
Gut (2013) Vol. 63, Iss. 4, pp. 674-685
Open Access | Times Cited: 246
Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step
Ralf Weiskirchen
Frontiers in Pharmacology (2016) Vol. 6
Open Access | Times Cited: 97
Ralf Weiskirchen
Frontiers in Pharmacology (2016) Vol. 6
Open Access | Times Cited: 97
CK19-positive Hepatocellular Carcinoma is a Characteristic Subtype
Jianyong Zhuo, Di Lu, Winyen Tan, et al.
Journal of Cancer (2020) Vol. 11, Iss. 17, pp. 5069-5077
Open Access | Times Cited: 87
Jianyong Zhuo, Di Lu, Winyen Tan, et al.
Journal of Cancer (2020) Vol. 11, Iss. 17, pp. 5069-5077
Open Access | Times Cited: 87
Diverse structures and antihepatoma effect of sesquiterpenoid dimers from Artemisia eriopoda by AKT/STAT signaling pathway
Xiaofeng He, Wenjing Ma, Jing Hu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 26
Xiaofeng He, Wenjing Ma, Jing Hu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 26
Conditional β-Catenin Loss in Mice Promotes Chemical Hepatocarcinogenesis: Role of Oxidative Stress and Platelet-Derived Growth Factor Receptor α/Phosphoinositide 3-Kinase Signaling†
Xu‐Feng Zhang, Xinping Tan, Gang Zeng, et al.
Hepatology (2010) Vol. 52, Iss. 3, pp. 954-965
Open Access | Times Cited: 94
Xu‐Feng Zhang, Xinping Tan, Gang Zeng, et al.
Hepatology (2010) Vol. 52, Iss. 3, pp. 954-965
Open Access | Times Cited: 94
No Correlation between the Expression of FXR and Genes Involved in Multidrug Resistance Phenotype of Primary Liver Tumors
P. Martinez-Becerra, Javier Vaquero, Marta R. Romero, et al.
Molecular Pharmaceutics (2012) Vol. 9, Iss. 6, pp. 1693-1704
Closed Access | Times Cited: 88
P. Martinez-Becerra, Javier Vaquero, Marta R. Romero, et al.
Molecular Pharmaceutics (2012) Vol. 9, Iss. 6, pp. 1693-1704
Closed Access | Times Cited: 88
Decorin deficiency promotes hepatic carcinogenesis
Zsolt Horváth, Ilona Kovalszky, Alexandra Fullár, et al.
Matrix Biology (2013) Vol. 35, pp. 194-205
Open Access | Times Cited: 77
Zsolt Horváth, Ilona Kovalszky, Alexandra Fullár, et al.
Matrix Biology (2013) Vol. 35, pp. 194-205
Open Access | Times Cited: 77
Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC)
Madhura Joglekar-Javadekar, Steven Van Laere, Michael H. Bourne, et al.
Neoplasia (2017) Vol. 19, Iss. 7, pp. 564-573
Open Access | Times Cited: 60
Madhura Joglekar-Javadekar, Steven Van Laere, Michael H. Bourne, et al.
Neoplasia (2017) Vol. 19, Iss. 7, pp. 564-573
Open Access | Times Cited: 60
Platelet Effects on Ovarian Cancer
Ashley N. Davis, Vahid Afshar‐Kharghan, Anil K. Sood
Seminars in Oncology (2014) Vol. 41, Iss. 3, pp. 378-384
Open Access | Times Cited: 57
Ashley N. Davis, Vahid Afshar‐Kharghan, Anil K. Sood
Seminars in Oncology (2014) Vol. 41, Iss. 3, pp. 378-384
Open Access | Times Cited: 57
Overexpression of platelet-derived growth factor receptor alpha promotes tumor progression and indicates poor prognosis in hepatocellular carcinoma
Wei Tao, Lína Zhang, Yi Lv, et al.
Oncotarget (2014) Vol. 5, Iss. 21, pp. 10307-10317
Open Access | Times Cited: 57
Wei Tao, Lína Zhang, Yi Lv, et al.
Oncotarget (2014) Vol. 5, Iss. 21, pp. 10307-10317
Open Access | Times Cited: 57
Decorin interferes with platelet‐derived growth factor receptor signaling in experimental hepatocarcinogenesis
Kornélia Baghy, Zsolt Horváth, Eszter Regős, et al.
FEBS Journal (2013) Vol. 280, Iss. 10, pp. 2150-2164
Open Access | Times Cited: 56
Kornélia Baghy, Zsolt Horváth, Eszter Regős, et al.
FEBS Journal (2013) Vol. 280, Iss. 10, pp. 2150-2164
Open Access | Times Cited: 56
Unique Molecular Characteristics of Pediatric Myxopapillary Ependymoma
Valerie N. Barton, Andrew M. Donson, Bette K. Kleinschmidt‐DeMasters, et al.
Brain Pathology (2009) Vol. 20, Iss. 3, pp. 560-570
Open Access | Times Cited: 61
Valerie N. Barton, Andrew M. Donson, Bette K. Kleinschmidt‐DeMasters, et al.
Brain Pathology (2009) Vol. 20, Iss. 3, pp. 560-570
Open Access | Times Cited: 61
Targeted therapy of hepatocellular cancer
Piotr J. Wysocki
Expert Opinion on Investigational Drugs (2010) Vol. 19, Iss. 2, pp. 265-274
Closed Access | Times Cited: 54
Piotr J. Wysocki
Expert Opinion on Investigational Drugs (2010) Vol. 19, Iss. 2, pp. 265-274
Closed Access | Times Cited: 54
PET Imaging of Receptor Tyrosine Kinases in Cancer
Weijun Wei, Dalong Ni, Emily B. Ehlerding, et al.
Molecular Cancer Therapeutics (2018) Vol. 17, Iss. 8, pp. 1625-1636
Open Access | Times Cited: 41
Weijun Wei, Dalong Ni, Emily B. Ehlerding, et al.
Molecular Cancer Therapeutics (2018) Vol. 17, Iss. 8, pp. 1625-1636
Open Access | Times Cited: 41
Platelet-derived growth factor receptor alpha (PDGFRα) targeting and relevant biomarkers in ovarian carcinoma
Koji Matsuo, Masato Nishimura, Kakajan Komurov, et al.
Gynecologic Oncology (2013) Vol. 132, Iss. 1, pp. 166-175
Open Access | Times Cited: 35
Koji Matsuo, Masato Nishimura, Kakajan Komurov, et al.
Gynecologic Oncology (2013) Vol. 132, Iss. 1, pp. 166-175
Open Access | Times Cited: 35
Pathogenesis and Prognosis of Hepatocellular Carcinoma at the Cellular and Molecular Levels
Olivier Govaere, Tania Roskams
Clinics in Liver Disease (2015) Vol. 19, Iss. 2, pp. 261-276
Closed Access | Times Cited: 31
Olivier Govaere, Tania Roskams
Clinics in Liver Disease (2015) Vol. 19, Iss. 2, pp. 261-276
Closed Access | Times Cited: 31
Platelet derived growth factor receptor alpha mediates nodal metastases in papillary thyroid cancer by driving the epithelial-mesenchymal transition
Esther Ekpe-Adewuyi, Ana Lopez-Campistrous, Xiaoyun Tang, et al.
Oncotarget (2016) Vol. 7, Iss. 50, pp. 83684-83700
Open Access | Times Cited: 31
Esther Ekpe-Adewuyi, Ana Lopez-Campistrous, Xiaoyun Tang, et al.
Oncotarget (2016) Vol. 7, Iss. 50, pp. 83684-83700
Open Access | Times Cited: 31
Activation of SRY accounts for male-specific hepatocarcinogenesis: Implication in gender disparity of hepatocellular carcinoma
Chang Liu, Yifan Ren, Jian Dong, et al.
Cancer Letters (2017) Vol. 410, pp. 20-31
Closed Access | Times Cited: 30
Chang Liu, Yifan Ren, Jian Dong, et al.
Cancer Letters (2017) Vol. 410, pp. 20-31
Closed Access | Times Cited: 30
PDGFRα in Liver Pathophysiology: Emerging Roles in Development, Regeneration, Fibrosis, and Cancer
Alexander Kikuchi, Satdarshan P. Monga
Gene Expression (2015) Vol. 16, Iss. 3, pp. 109-127
Open Access | Times Cited: 29
Alexander Kikuchi, Satdarshan P. Monga
Gene Expression (2015) Vol. 16, Iss. 3, pp. 109-127
Open Access | Times Cited: 29
Platelet-derived growth factor receptor tyrosine kinase inhibitors: a review of the recent patent literature
Yujia Dai
Expert Opinion on Therapeutic Patents (2010) Vol. 20, Iss. 7, pp. 885-897
Closed Access | Times Cited: 35
Yujia Dai
Expert Opinion on Therapeutic Patents (2010) Vol. 20, Iss. 7, pp. 885-897
Closed Access | Times Cited: 35
β-Catenin Loss in Hepatocytes Promotes Hepatocellular Cancer after Diethylnitrosamine and Phenobarbital Administration to Mice
Prince Awuah, Byung Han Rhieu, Sucha Singh, et al.
PLoS ONE (2012) Vol. 7, Iss. 6, pp. e39771-e39771
Open Access | Times Cited: 30
Prince Awuah, Byung Han Rhieu, Sucha Singh, et al.
PLoS ONE (2012) Vol. 7, Iss. 6, pp. e39771-e39771
Open Access | Times Cited: 30
Role and Regulation of PDGFRα Signaling in Liver Development and Regeneration
Prince Awuah, Kari Nejak‐Bowen, Satdarshan P. Monga
American Journal Of Pathology (2013) Vol. 182, Iss. 5, pp. 1648-1658
Open Access | Times Cited: 27
Prince Awuah, Kari Nejak‐Bowen, Satdarshan P. Monga
American Journal Of Pathology (2013) Vol. 182, Iss. 5, pp. 1648-1658
Open Access | Times Cited: 27
Novel 2-phenyloxypyrimidine derivative induces apoptosis and autophagy via inhibiting PI3K pathway and activating MAPK/ERK signaling in hepatocellular carcinoma cells
Jing Wang, Peng Sun, Yijun Chen, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 22
Jing Wang, Peng Sun, Yijun Chen, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 22
Selective deletion of hepatocyte platelet-derived growth factor receptor α and development of liver fibrosis in mice
Beom Jin Lim, Woon-Kyu Lee, Hyun Woong Lee, et al.
Cell Communication and Signaling (2018) Vol. 16, Iss. 1
Open Access | Times Cited: 21
Beom Jin Lim, Woon-Kyu Lee, Hyun Woong Lee, et al.
Cell Communication and Signaling (2018) Vol. 16, Iss. 1
Open Access | Times Cited: 21
Clinically Relevant Biomarkers to Select Patients for Targeted Inhibitor Therapy after Resection of Hepatocellular Carcinoma
Sameer H. Patel, Peter J. Kneuertz, Maria Delgado, et al.
Annals of Surgical Oncology (2011) Vol. 18, Iss. 12
Closed Access | Times Cited: 21
Sameer H. Patel, Peter J. Kneuertz, Maria Delgado, et al.
Annals of Surgical Oncology (2011) Vol. 18, Iss. 12
Closed Access | Times Cited: 21
